FDA Adverse Event Injury Summary report: N

SYNCHROMED EL

MDR report key: 1344911 · Received March 16, 2009

Report

Report Number
2182207-2009-01858
Event Type
Injury
Date Received
March 16, 2009
Date of Event
August 1, 2008
Report Date
February 17, 2009
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

LITERATURE: UETA T. (INTRATHECAL BACLOFEN FOR SEVERE SPASTICITY]. BRAIN NERVE. 2008-60(12): 1415-1420. SUMMARY: THIS STUDY EVALUATED 40 PTS FROM 2002 - 2008 FOR USE OF INTRATHECAL BACLOFEN FOR THE CONTROL OF SPASTICITY. DURING SCREENING TRIAL WITH INTRATHECAL BACLOFEN, PT EXPERIENCED MARKED DECREASE IN LOWER EXTREMITY SPASTICITY. EFFECTS WERE EXPERIENCED FROM APPROX 2 - 12 HOURS FOLLOWING LUMBAR PUNCTURE. THE EFFECTS GRADUALLY DIMINISHED AND DISAPPEARED COMPLETELY BETWEEN 24 - 36 HOURS AFTER ADMINISTRATION. SOME COMPLICATIONS WERE MILD DECREASE IN BLOOD PRESSURE AND CEPHALALGIA - NOT REQUIRING TREATMENT. AFTER PUMP IMPLANTATION PT EXPERIENCED A DISAPPEARANCE OF BINDING SENSATION IN TRUNCAL AREA; EASIER BREATHING; BETTER SLEEP; NIGHTTIME RESTRAINING BANDS REMOVED; IMPROVEMENTS IN ANTEFLEXION; IMPROVEMENTS IN PRESSURE SORES AND GENERAL IMPROVEMENT IN MOBILITY. AN INFECTION IN THE INCISION AREA DID NOT HEAL AND ALL EQUIPMENT, INCLUDING THE PUMP AND CATHETER, HAD TO BE REMOVED. THE PT STRONGLY DESIRED THAT THE PUMP BE RE-IMPLANTED, IMPLANTATION WAS PERFORMED ON THE OPPOSITE SIDE AND BACLOFEN ADMINISTRATION WAS RE-STARTED. FOUR YEARS HAVE SINCE PASSED, AND THE SPASTICITY IS BEING CONTROLLED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SYNCHROMED EL LKK MEDTRONIC NEUROMODULATION 8627 NA

Patients

Seq Age Sex Outcome Treatment
1 51 YR Required Intervention CATHETER: MODEL CATHETER| IMPLANTED:| PROGRAMMER: MODEL PROGRAMMER| EXPLANTED:| EXPLANTED:| IMPLANTED: